Our findings indicated that miR-506 was down-regulated and might act as a tumor suppressor by directly targeting FLOT1 in renal cancer, suggesting that miR-506 has a potential role in the diagnosis and therapy of renal cancer. Here, FLOT1 is linked to renal carcinoma.